SIOPEN

  • International Society of Paediatric Oncology Europe Neuroblastoma

welcome.jpg

baby_hands_small.jpg

 

SIOPEN brings together clinicians from across Europe and beyond to improve the outcomes for patients with neuroblastoma.

International collaboration is vital because neuroblastoma is uncommon. Collaboration ensures there are enough patients to do clinical studies. This allows us to learn more about the condition and improve treatments. SIOPEN runs a number of large clinical trials examining how best to treat neuroblastoma.

In addition, it leads research into the biology of neuroblastoma to provide a better understanding of how the disease develops and how these different types respond to treatment. There are Speciality Committees which focus on specific areas such as biology, pathology, imaging techniques, molecular monitoring of response and surgery. Further information can be found in the relevant sections of this website.

SIOPEN meetings

Forthcoming meetings:

Berlin (Germany) AGM

25-27 October 2017 

click for more information

SIOPEN

SIOPEN Verein zur Foderung der Neuroblastomforschung is an Association registered in Austria and recognised as a non-profit organisation according to the Austrian Federal Tax Code (Bundesabgabenordnung BAO). Registration number ZVR 396592912. The SIOPEN Association was officially established on 20 January 2009.

This website makes use of stock photography and images do not represent particular individuals treated by SIOPEN institutions.